Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,425,224,575
+$74,932,998 QoQ
Shares Held
18,873,343
-3.4% QoQ
Ownership
0.765%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#18
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $26,335,991,083 across 11 Drug Manufacturers - General names. MRK ranks #5 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,145,229 | $6,171,342,532 | |
| 2 | JNJ |
Johnson & Johnson
|
19,286,904 | $4,898,295,007 | |
| 3 | AZN |
Astrazeneca PLC
|
25,750,245 | $4,882,761,455 | |
| 4 | ABBV |
AbbVie Inc.
|
11,548,053 | $2,905,952,055 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
18,873,343 | $2,425,224,575 | |
| 6 | AMGN |
Amgen Inc
|
3,816,942 | $1,382,191,036 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
10,421,131 | $1,316,605,688 | |
| 8 | PFE |
Pfizer Inc
|
43,233,122 | $1,041,053,576 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,425,224,575 | 18,873,343 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,350,291,577 | 19,538,545 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,081,710,387 | 19,776,842 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,733,923,046 | 20,659,157 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,543,861,040 | 19,503,045 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,773,236,444 | 19,755,308 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,938,319,152 | 19,484,511 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,185,212,593 | 19,242,802 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $2,313,463,846 | 18,687,107 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $2,539,118,467 | 19,243,035 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $2,113,645,199 | 19,387,683 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $2,073,380,776 | 20,139,687 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,386,911,844 | 20,685,604 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,083,953,382 | 19,587,869 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,129,088,006 | 19,189,617 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,696,961,185 | 19,704,612 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,848,896,327 | 20,279,657 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $1,665,373,444 | 20,297,056 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,464,162,211 | 19,104,413 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,435,849,777 | 19,116,626 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,421,963,554 | 18,284,217 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,311,670,482 | 17,014,785 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,413,101,153 | 17,275,083 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,412,252,937 | 17,025,344 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,333,723,538 | 17,247,161 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,302,629,203 | 16,930,462 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||